Literature DB >> 34854927

Interobserver variability in MRI measurements of mesorectal invasion depth in rectal cancer.

Mariana M Chaves1, Henrique Donato2, Nuno Campos2, David Silva3, Luís Curvo-Semedo2,4.   

Abstract

PROPOSE: To assess the interobserver variability in MRI measurements of mesorectal invasion depth (MID) in rectal adenocarcinomas primarily staged as T3, by determining the level of interobserver agreement in the differentiation of individual T3 substages and of T3a-b vs. T3c-d disease, between readers with different levels of expertise.
METHODS: A retrospective analysis of 60 patients classified by MRI as having T3 rectal cancers was performed. Each patient underwent MR examination in a 1.5 T machine and the standard imaging protocol included a high-resolution axial T2-weighted sequence in which the measurements were determined by independent radiologists (readers A and B, with 15 years and 1 year of experience, respectively). The rectum was further divided into quadrants and each reader selected the quadrant where the measurement was taken. The patients were grouped according to the MID (T3a < 1 mm; T3b 1-5 mm; T3c > 5-15 mm; T3d > 15 mm) and the interobserver reliability was tested using Cohen's kappa.
RESULTS: Population included 40 males and 20 females with a median age of 65.9 years. Interobserver agreement on individual substage differentiation (T3 a, b, c and d) was moderate (K = 0.428) and in the quadrant evaluation the level of agreement was also moderate (K = 0.414). Nevertheless, the interobserver reliability for the differentiation between stages T3a-b vs. T3c-d was substantial (K = 0.697).
CONCLUSIONS: There is no considerable interobserver variability when distinguishing T3a-b from T3c-d tumors, regardless of the quadrant where the MID is measured. Therefore, assessment of MID, for that purpose, is a reproducible MR parameter, irrespectively of the readers' experience.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Magnetic resonance imaging; Mesorectal invasion depth; Rectal cancer; T3 substaging

Mesh:

Year:  2021        PMID: 34854927     DOI: 10.1007/s00261-021-03363-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  13 in total

1.  Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging.

Authors:  Chan Kyo Kim; Seung Hoon Kim; Ho Kyung Chun; Woo-Yong Lee; Seong-Hyeon Yun; Sang-Yong Song; Dongil Choi; Hyo Keun Lim; Min Ju Kim; Jongmee Lee; Soon Jin Lee
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

2.  MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.

Authors:  Hayeong Park; Kyung Ah Kim; Ji-Han Jung; Jeongbae Rhie; Sun Young Choi
Journal:  Eur Radiol       Date:  2020-04-08       Impact factor: 5.315

Review 3.  Rectal Cancer: Staging.

Authors:  Luís Curvo-Semedo
Journal:  Magn Reson Imaging Clin N Am       Date:  2019-11-01       Impact factor: 2.266

4.  Rectal carcinoma: thin-section MR imaging for staging in 28 patients.

Authors:  G Brown; C J Richards; R G Newcombe; N S Dallimore; A G Radcliffe; D P Carey; M W Bourne; G T Williams
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

5.  Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography.

Authors:  L Blomqvist; M Machado; C Rubio; N Gabrielsson; S Granqvist; S Goldman; T Holm
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

6.  Mesorectal Invasion Depth in Rectal Carcinoma Is Associated With Low Survival.

Authors:  Leonardo S Lino-Silva; Reynaldo Loaeza-Belmont; Miguel A Gómez Álvarez; Itzel Vela-Sarmiento; José M Aguilar-Romero; Jorge A Domínguez-Rodríguez; Rosa A Salcedo-Hernández; Erika B Ruiz-García; Héctor A Maldonado-Martínez; Ángel Herrera-Gómez
Journal:  Clin Colorectal Cancer       Date:  2016-06-08       Impact factor: 4.481

Review 7.  Neo-adjuvant radiotherapy in rectal cancer.

Authors:  Bengt Glimelius
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

8.  Correction to: Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.

Authors:  Regina G H Beets-Tan; Doenja M J Lambregts; Monique Maas; Shandra Bipat; Brunella Barbaro; Luís Curvo-Semedo; Helen M Fenlon; Marc J Gollub; Sofia Gourtsoyianni; Steve Halligan; Christine Hoeffel; Seung Ho Kim; Andrea Laghi; Andrea Maier; Søren R Rafaelsen; Jaap Stoker; Stuart A Taylor; Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2018-06       Impact factor: 5.315

Review 9.  A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Authors:  Yi Li; Ji Wang; Xiaowei Ma; Li Tan; Yanli Yan; Chaofan Xue; Beina Hui; Rui Liu; Hailin Ma; Juan Ren
Journal:  Int J Biol Sci       Date:  2016-07-17       Impact factor: 6.580

10.  The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.

Authors:  Chaoyang Gu; Xuyang Yang; Xubing Zhang; Erliang Zheng; Xiangbing Deng; Tao Hu; Qingbin Wu; Liang Bi; Bing Wu; Minggang Su; Ziqiang Wang
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.